Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | CTRC | Q99895 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25752165 | 0.79 | F2 (0.35) | F2ELANECTSGCTRC | |
| SCHEMBL7770113 | 0.74 | PER2 (0.35) | F2ELANECTSGCTRCGAA | |
| SCHEMBL6543606 | 0.74 | PIK3CD (0.50) | ALDH1A1MAPK1 | |
| SCHEMBL9129409 | 0.71 | L3MBTL1 (0.45) | ALDH1A1MAPK1GAA | |
| SCHEMBL27797024 | 0.71 | CYP3A4 (0.38) | ALDH1A1F2ELANECTSGCTRC | |
| SCHEMBL329869 | 0.71 | F2 (0.45) | ALDH1A1F2ELANECTSGCTRC | |
| SCHEMBL462082 | 0.70 | CYP3A4 (0.46) | ALDH1A1GAA | |
| SCHEMBL22700978 | 0.70 | DPP4 (0.35) | ALDH1A1 | |
| SCHEMBL11560070 | 0.67 | FAAH (0.38) | CA12CA2CA9GAA | |
| SCHEMBL21410483 | 0.67 | FAAH (0.38) | CA12CA2CA9GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | SHIKOKU CHEMICALS CORPORATION (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | TMT1A, CTH, SLC7A11 | ALDH1A1 81/4885MAPK1 3313/4885CA12 3722/4885 |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | TMT1A, CTH, SLC7A11 | ALDH1A1 81/4885MAPK1 3313/4885CA12 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.